These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23358137)

  • 1. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.
    Haleagrahara N; Siew CJ; Ponnusamy K
    J Toxicol Sci; 2013 Feb; 38(1):25-33. PubMed ID: 23358137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.
    Haleagrahara N; Siew CJ; Mitra NK; Kumari M
    Neurosci Lett; 2011 Aug; 500(2):139-43. PubMed ID: 21704673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.
    Lv H; Liu J; Wang L; Zhang H; Yu S; Li Z; Jiang F; Niu Y; Yuan J; Cui X; Wang W
    Cell Biochem Biophys; 2014 Nov; 70(2):1433-8. PubMed ID: 24989681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
    Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
    Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6-hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels.
    Mannan Thodukayil N; Antony J; Thomas P; Jeyarani V; Choephel T; Manisha C; Jose A; Karolina Sahadevan S; Kannan E
    J Pharm Pharmacol; 2019 Aug; 71(8):1271-1281. PubMed ID: 31144300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
    Singh S; Ahmad R; Mathur D; Sagar RK; Krishana B
    Indian J Exp Biol; 2006 Sep; 44(9):699-704. PubMed ID: 16999024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease.
    Abuthawabeh R; Abuirmeileh AN; Alzoubi KH
    Restor Neurol Neurosci; 2020; 38(5):369-373. PubMed ID: 32986633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Kumari R; Kumar JB; Luthra PM
    Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats.
    Mu X; Yuan X; Du LD; He GR; Du GH
    J Asian Nat Prod Res; 2016; 18(1):65-71. PubMed ID: 26217978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
    Yelkenli İH; Ulupinar E; Korkmaz OT; Şener E; Kuş G; Filiz Z; Tunçel N
    J Mol Neurosci; 2016 Jun; 59(2):280-9. PubMed ID: 27115671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
    Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
    Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
    Dluzen D
    Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.
    Yin SM; Zhao D; Yu DQ; Li SL; An D; Peng Y; Xu H; Sun YP; Wang DM; Zhao J; Zhang WQ
    Sheng Li Xue Bao; 2014 Dec; 66(6):658-66. PubMed ID: 25516514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.